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        Native subtypes of K 
+   and other ion channels are often 
hetero-oligomeric combinations of protein subunits. 
Drugs that selectively target relevant in vivo heteromers 
are valuable research tools and potential therapeutics. 
To recreate heteromeric channels as authentic drug tar-
gets, multiple subunits have been covalently tethered by 
concatemerizing their coding sequences. This perspec-
tive examines the linking strategies that have proven 
successful with many channel types and addresses some 
less desirable outcomes encountered. We discuss a vari-
ety of biochemical, electrophysiological, and pharmaco-
logical techniques that can assess whether constructs 
with concatenated subunits lead to expression of the in-
tended uniform population of channels. Careful con-
trols to ensure that channels are properly assembled can 
validate heterologously expressed concatemers as prom-
ising targets for the discovery of highly selective drugs. 
  Introduction 
  It has long been known that the ionic conduction path-
ways of many native channels are formed by combinato-
rial associations of homologous protein subunits. The 
time has now come to drug these tissue-specifi  c hetero-
multimers. Therapeutic discovery strategies most com-
monly screen for ligands that bind homo-oligomers of 
only one channel constituent, and are liable to produce 
drugs that affect any tissue expressing that particular 
subunit. Drugs selective for tissue-specifi  c hetero-oligo-
mers are valuable as research tools to establish the mo-
lecular identity of native channel subtypes, and possibly 
as therapeutics with reduced side effects. To fi  nd het-
eromer-specifi  c drugs, a means of reliably expressing a 
uniform population of channels with defi  ned subunit 
combinations is prerequisite. For some channel types, 
this can be achieved by expression from a coding se-
quence composed of genes for multiple subunits con-
catenated into one open reading frame. Technically, 
this has been realized by removal of the 3     stop codon 
from initial subunits and replacement with a linker to 
the 5     end of another subunit  ’  s sequence. The resultant 
protein then has the C terminus of initial subunits cova-
lently attached to the N terminus of following subunits. 
Such contiguous proteins are commonly referred to as 
    Abbreviations used in this paper: Kv,   Shaker  -related voltage-gated K 
+   
channel family; CNG, cyclic nucleotide-gated; GABA  A  ,     -aminobutyric 
acid type A; nAChR, nicotinic acetylcholine receptor. 
tethered, tandem, linked, or concatenated, the latter 
being our favored term. In theory, when subunits are 
concatenated, their proximity to each other greatly 
favors self-assembly, as their relative local concentration 
exceeds that of subunits synthesized by other ribosomes. 
In practice, assembly is contingent upon many factors, 
including the energetics of intersubunit interaction. 
This perspective draws primarily upon our experience 
with K 
+   channel concatemers; it is a view toward con-
trols and precautions that can be taken when working 
with such constructs to validate their use for discovery 
of heteromer-specifi  c therapeutics. 
  Successful and Problematic Concatenation Strategies 
  The scientifi  c merits of linking subunits are evidenced 
by the plethora of careful studies that have used the 
strategy. Concatenation can yield much more uniform 
populations of hetero-oligomers than coexpression 
methodologies; yet, this technique does not work per-
fectly for every construct. Years of work by many labora-
tories have shown the great advantages and occasional 
limitations of the use of linked constructs; here we touch 
on some telling examples. 
  Voltage-gated K 
+   Channels.     The pore-forming subunits 
of   Shaker  -related voltage-gated K 
+   channel family (Kv) 
channels were concatenated soon after their initial 
cloning and functional expression (  Isacoff et al., 1990  ). 
Kv proteins extend both their N and C termini into the 
cytoplasm and subunits linked as tetramers bear an ar-
chitectural resemblance to the domain structure of volt-
age-gated Na 
+   and Ca 
+   channels. This structural relation 
may explain why cells have been able to express a diversity 
of Kv subunits stitched together into Frankenstein chan-
nels. Many constructs have reliably produced the 
intended linked tetramers, and extensive controls dem-
onstrated that a uniform population of heteromeric chan-
nels containing the intended subunits can be expressed 
in the plasmalemma (  Heginbotham and MacKinnon, 
1992  ;   Hurst et al., 1992  ;   Kavanaugh et al., 1992  ;   Liman 
et al., 1992  ). With some constructs, however, there was 
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of just the right length, certain orderings of subunits ex-
press a higher proportion of functional channels and 
these combinations have been identifi  ed as candidates 
for native GABA  A   subtypes. Concatemers have also been 
used to constrain nicotinic acetylcholine receptor 
(nAChR) stoichiometry (for review see   White, 2006  ). 
Linkage of nAChR subunits has sometimes resulted in 
receptors that function well, while other concatemers 
exhibit bizarre behavior indicative of inappropriate as-
sembly (  Groot-Kormelink et al., 2004  ). The linking of hu-
man nAChR subunits has even led to the tethered proteins 
covalently linking one complex to another, mimicking 
the dimeric receptor structure found in   Torpedo   (  Zhou 
et al., 2003  ). Pentameric concatemers of nAChR subunits 
were found to assemble into functional channels, and have 
even been shown to prevent inclusion of coexpressed 
monomeric subunits (  Groot-  Kormelink et al., 2006  ). This 
exclusionist behavior was similar to that of successfully 
concatenated Kv1 channels (  Liman et al., 1992  ) and fur-
ther validated the linking strategy for nAChR channels. 
  Generalizable Findings with Concatemers 
  The above studies are mentioned to highlight past tri-
umphs, and pitfalls to be wary of, when endeavoring to 
use this auspicious approach. Analysis of published fi  nd-
ings suggest it is unwise to assume a priori that the trans-
lation product of everything encoded in a concatenated 
DNA will be incorporated into a functional ion chan-
nel. Some lessons that have emerged from these studies 
are as follows. 
  (a) Work with nature! Intersubunit interfaces do not 
allow all heteromeric assemblies, but if concatemers 
are designed to imitate subunit combinations that 
occur in vivo, then the odds of assembly as planned 
are high. 
  (b) Although the majority of concatemeric channels 
may form correctly, assembly energetics could leave a 
fraction with an unexpected subunit stoichiometry. 
  (c) Every concatemer is different and, thus, must be 
individually validated. 
  (d) Do not let a few examples of meddlesome con-
catemers turn one off from a valuable tool. 
  Approaches to Validate the Uniformity and Stoichiometry 
of Expressed Concatemers 
  The key question to be asked by a concatemer validator 
is: are the expressed channels a uniform population 
comprised of the expected subunits? Researchers have 
at their disposal a wide variety of tools to address this is-
sue. Which controls are chosen and what level of het-
erogeneity can be accepted are, of course, specifi  c to 
each study  ’  s tolerances. For any validation, a useful test 
is to rearrange subunits in different expression con-
structs and assess the impact of positioning. Beyond 
this, there is a variety of means to assess the success of a 
concatenation strategy; it is worth contemplating the 
evidence that concatenated subunits do not always cre-
ate functional channels of the desired stoichiometry, 
with overrepresentation of the initial subunits or under-
representation of mutant subunits (  McCormack et al., 
1992a  ;   Hurst et al., 1995  ). These latter studies seem to 
have inordinately discouraged researchers who have 
considered using concatemers. When read critically, these 
works do not invalidate other fi  ndings using linked Kv 
constructs, but do highlight the need to run appropri-
ate controls to assess the uniformity and subunit stoichi-
ometry of the channels expressed. 
  Cyclic Nucleotide-gated Channels.     Kv channels are struc-
turally related to cyclic nucleotide-gated (CNG) chan-
nels and have been extensively studied via concatenation. 
This has led to a number of useful fi  ndings and, again, 
some constructs were found to behave better than oth-
ers. The ordering of CNG subunits in several tandem 
constructs appeared to affect their arrangement in the 
expressed channel (  Gordon et al., 1996  ;   Liu et al., 1996  ). 
However, another linkage of CNG subunits did not affect 
their rotational placement within channels (  Morrill and 
MacKinnon, 1999  ), indicating that some concatemeric 
constructs control subunit assembly more tightly than 
others. There is at least one instance of markedly un-
expected assembly of concatenated CNG subunits. An 
early study concluded it was possible that concatenated 
constructs bearing two CNG      subunits may not have in-
serted both      subunits into a functional channel (  Shapiro 
and Zagotta, 1998  ). This cautious interpretation of 
results later proved prudent, as several independent 
assessment methods determined that CNG channels are 
not able to assemble with more than one pore-forming 
    -subunit per channel (  Weitz et al., 2002  ;   Zheng et al., 
2002  ;   Zhong et al., 2002  ). Thus, the tethered      subunits 
were not all included in the channels they were engineered 
to; concatemerization could not force an unnatural union 
of pore-forming subunits. 
  Pentameric Ligand-gated Channels.     The ionotropic   “  Cys-
loop  ”   receptors are channels composed of fi  ve subunits 
that each have their N and C termini on the extracellu-
lar side of the plasmalemma, making these channels at-
tractive targets for concatenation. Thorough and careful 
work has validated strategies to engineer linked subunits 
of the     -aminobutyric acid type A (GABA  A  ) receptor 
(for review see   Minier and Sigel, 2004  ), and fully concat-
enated pentameric GABA  A   channels have been func-
tionally expressed in mammalian cells and   Xenopus   
oocytes (  Baur et al., 2006  ). While some constructs pro-
duced the intended heteromers, others expressed 
poorly or behaved strangely. Intersubunit linker length 
has been shown to be important: linkers that are too 
short may physically constrain channels and lead to low-
ered GABA sensitivity; whereas those overly long lead to 
degenerate assembly (  Baumann et al., 2001  ). With linkers     Sack et al.  417
with other Kv1 subunits, fast inactivation is absent in 
heteromers comprised of Kv1.4 and Kv1.6 (  Roeper 
et al., 1998  ). 
  For the analysis of voltage-gated channels, their con-
ductance  –  voltage (g-V) relation is a standard metric 
and has been used to validate the proper assembly of 
concatemeric proteins. A g-V plot well fi  t by a single 
Boltzmann distribution is consistent with a uniform 
population of channels, while a g-V too complex to be 
fi  t by a single Boltzmann can be refl  ective of multiple 
channel types. One should be aware that the complex 
gating of a uniform channel population could also lead 
to a complicated g-V relation. As an example, some Kv 
channels have a voltage-dependent fl  icker (  Hoshi et al., 
1994  ) that causes their open probability to continue in-
creasing at positive voltages beyond that predicted by 
a single Boltzmann distribution. In consequence, pub-
lished g-V relations are often trimmed to voltage ranges 
over which the Boltzmann equation fi  ts nicely. This be-
ing kept in mind, the midpoint and slope of these fi  ts 
have been very useful measurements. Parameters of 
Boltzmann fi  ts have been used to assert that subunit 
utility and limitation of the different techniques avail-
able. These can be subcategorized by discipline into 
biochemical, electrophysiological, and pharmacologi-
cal methods  —  we believe the best validation strategy is 
to use a combination of all three. 
  Biochemical Validation  —  Are the Surface Proteins Intact?     A 
basic assessment of the size of an expressed channel can 
be surprisingly informative. Expressed protein may be 
truncated in such a manner that, if recognized, would 
alter interpretation of results. Controls indicating that 
concatenated proteins expressed are of the expected 
size can allay concerns about truncated concatemers. 
The fi  ndings of Annette Nicke and colleagues (  Nicke 
et al., 2003  ) should strike fear in the hearts of those who 
trust concatemers to remain intact in the plasma mem-
brane. Their attempted biochemical validation of con-
catenated P2X  1   receptors found that, despite the 
predominance of full-length concatemeric protein in 
  Xenopus   oocytes, the surface channels were comprised 
of degraded monomeric and dimeric constituents. Our 
laboratory has chosen to work with Kv1 concatemers ex-
pressed in HEK 293 cells, as Western blots indicate the 
predominant protein produced remains full length 
(  Sokolov et al., 2007  ). In contrast, some breakdown of 
linked Kv1 channel proteins has been seen in blots of 
transfected COS-7 and CHO cells. However, examina-
tion of biotinylated surface channel protein in CHO 
cells indicated that the plasma membrane channels are 
intact (Fig. 1).   It seems, thankfully, that the opposite of 
the concatenated P2X  1   phenomenon occurs when ex-
pressing linked Kv1 subunits. In fact, no biochemical 
evidence exists in the literature (or our laboratory) to 
indicate signifi  cant amounts of degraded or truncated 
Kv1 concatemer on the surface of any mammalian cell. 
Even if degraded concatemers were to be found, it is 
possible that channels assembled as intact concatemers 
could be later nicked by proteases to lose their covalent 
connection, yet remain as channels of the expected 
stoichiometry. A convincing validation of this situation 
could prove diffi  cult; although evidence could be ob-
tained through electrophysiological and pharmacologi-
cal means. 
  Electrophysiological Validation  —  A Concatenated Product 
Is More than the Sum of its Parts.     Characterization of ionic 
currents is an indispensable part of any channel valida-
tion strategy and can be used to assess the uniformity of 
expressed channels. Electrophysiological recordings 
can indicate the presence of subunits that endow chan-
nels with a particular property (e.g., inactivation, de-
sensitization, ionic selectivity, altered voltage sensitivity), 
although properties of parental homomers are not 
always refl  ected in their heteromeric offspring. A strik-
ing example: while the N-type inactivation associated 
with Kv1.4 currents has been a hallmark of coassembly 
  Figure 1.     Surface biotinylation of heteromeric Kv1 concatemers 
expressed in CHO cells. Concatenated constructs of Kv1.1-1.2 or 
Kv1.1-1.2-1.2-1.2 (Akhtar et al., 2002) were expressed CHO cells 
by electroporation of RNA transcripts from a Semliki Forest vi-
rus vector. After 48 h, electroporated cells were harvested in PBS 
buffer containing 5 mM EDTA. Cell surface biotinylation was 
performed with sulfo-NHS-LC-biotin (Pierce Chemical Co.), as 
recommended by the manufacturer. Membrane proteins solubi-
lized with 2% Triton X-100 were precipitated using streptavidin-
agarose (Pierce Chemical Co.). Bound proteins were dissolved in 
lithium dodecyl sulfate sample buffer (Invitrogen) and SDS-PAGE 
and Western blotting with anti-Kv1.2 antibody were performed, as 
outlined elsewhere (Akhtar et al., 2002). Lanes: 1, biotinylated 
Kv1.1-1.2; 2, total extract from cells expressing Kv1.1-1.2; 3, bioti-
nylated Kv1.1-1.2-1.2-1.2; and 4, total extract from cells expressing 
Kv1.1-1.2-1.2-1.2.     418   Concatemer Validation 
ability of labeled pore-blocking peptide toxins such as 
 
125  I-    dendrotoxin,  
125  I-dendrotoxin  k   ( Wang et al., 1999a ), 
and  
125  I-hongotoxin  1   Y19F/A37Y (  Koschak et al., 1998  ), 
which have slow dissociation rates suffi  cient to allow re-
tention of bound radioligand during washes. The pre-
cise structures of dose  –  response profi  les obtained with 
this technique have been quite revealing, and multipha-
sic radioligand displacement profi  les have been used 
to expose the heterogeneity of some Kv1 concatemers 
(  Middleton et al., 2003  ). Although researchers should 
remember that heteromers do not always retain the 
pharmacology one might predict from their monomeric 
substituents, drugs can be used to demonstrate a sub-
unit  ’  s inclusion in channels. For example, the Kv1.1-
specifi  c dendrotoxin  k   from mamba snake venom has 
bound all Kv1 heteromers tested to date that contain at 
least one Kv1.1 subunit. Therefore, dendrotoxin  k   bind-
ing to heteromeric channels verifi  es the presence of 
Kv1.1, and has provided a means of validating the uni-
formity of concatemers (  Akhtar et al., 2002  ). 
  How to Find a Heteromer-speciﬁ  c Drug 
  To validate recombinant ion channels as therapeutic 
targets, the big question is: which subunit combinations 
are relevant in vivo? The clearest conclusions concern-
ing the identity of native Kv1 heterotetramers have been 
gleaned from successive immunoprecipitation experi-
ments, a technique that proved to be capable of defi  ni-
tively identifying the underlying oligomer when channels 
were composed of four different      subunits. Interest-
ingly, out of the vast number of potential heteromers, a 
handful of Kv1 subunit combinations were seen to be 
predominant in mammalian brain (  Shamotienko et al., 
1997  ;   Koschak et al., 1998  ;   Coleman et al., 1999  ;   Wang 
et al., 1999b  ). At the International Centre for Neuro-
therapeutics, we have embarked on a program seeking 
drugs specifi  c to concatemeric recreations of these na-
tive Kv1 heterotetramers. 
  Does it ever seem queer that the K 
+   channel pore-
blocking peptides from venomous creatures use an 
asymmetrical scaffold to bind to fourfold symmetric 
channels? This might seem less strange when one con-
siders that heteromers may be the in vivo targets of most 
venom peptides. The majority of studies using these 
toxins have been conducted on homomeric channels 
merely because homomers are more straightforward 
for researchers to express. By virtue of binding along the 
central axis of K 
+   permeation, pore-blocking peptide 
toxins present a unique interaction face to each channel 
subunit. The subunit-spanning design imbues the pep-
tides with an exquisite ability to distinguish heteromers. 
A derivative of the ShK anemone toxin serves as a poignant 
example; it has been found to displace radioligand from 
heteromeric channels containing both Kv1.1 and Kv1.2 
at concentrations too dilute to bind either parental 
homo-tetramer (  Middleton et al., 2003  ). This fi  nding is 
order in the concatemeric coding sequence affected 
the stoichiometry of expressed Kv channels (  McCor-
mack et al., 1992b  ), and the ability of a single Boltzmann, 
rather than the sum of multiple, to fi  t g-V relations has 
been used to assess whether or not channel subunits 
coassemble (  Lee et al., 1994  ). 
  Ion channel kinetics are often well described by sim-
ple equations that can be used to assess the uniformity 
of a channel population. Current recordings that can 
be fi  t with a single exponential function, or the product 
of multiple exponentials, are refl  ective of conforma-
tional change occurring with the same energetics 
throughout an entire channel population, and suggest 
that the underlying channels are similar. In contrast, 
mixed populations of channels with different kinetics 
will require fi  tting with the sum of multiple functions. 
Currents from concatemers that were distinct from 
those of their parental homomers and have kinetics 
that can be fi  t with exponential decay have indicated 
expression of a uniform population of heteromers 
(  Sokolov et al., 2007  ). 
  Pharmacological Validation  —  Are Dose  –  Response Proﬁ  les 
Sensical?     Drug effectiveness can provide insights into 
the make-up of expressed channels. Equations from sto-
chastic physics determine the theoretical concentration 
dependence of ligand binding and can be useful for 
validating the uniformity of concatemers. A ligand that 
binds to any population of identical channels with a 1:1 
stoichiometry should obey a standard Langmuir bind-
ing isotherm, and the binding curve should be fi  tted by 
a Hill equation with a slope of one. The Hill equation 
can be a powerful tool for demonstrating uniformity, as 
subpopulations of binding sites with different affi  nities 
will produce a multiphasic dose  –  response profi  le that 
will shallow the slope of attempted fi  ts. A Hill slope 
steeper than predicted can be a consequence of signifi  -
cant depletion of dilute concentrations of drugs from 
solutions. For K 
+   channels, external TEA dose  –  response 
can be a telling means to assess channel stoichiometry, 
as the ligand  –  channel interaction is quite well under-
stood. Each subunit appears to contribute a constant 
energy regardless of its positional arrangement, and de-
tailed electrophysiological measurements of K 
+   current 
inhibition by external TEA have been a primary method 
to validate assembly of Kv1 concatemeric constructs 
(  Heginbotham and MacKinnon, 1992  ;   Kavanaugh et al., 
1992  ;   Liman et al., 1992  ). 
  While detailed dose responses to drugs can be useful 
in assessing channel uniformity, the limited lifetime of 
most electrophysiological recordings can make such 
measurements diffi  cult with slow-acting drugs. The de-
velopment of techniques to measure displacement of 
high-affi  nity radioligands from ion channels has pro-
vided an effi  cient means to measure drug binding. A 
benefi  t of working with certain Kv1 channels is the avail-    Sack et al.  419
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remarkable, because it is one of the few instances where 
the affi  nity of a pore-blocking peptide toxin has been 
determined for a defi  ned heterotetramer (also   Akhtar 
et al., 2002  ), and begs the question of what other het-
eromer-specifi  c toxins are harbored in the poison glands 
of creatures worldwide. 
  As a parting note, we mention another promising route 
to the discovery of drugs imbued with heteromeric 
specifi  city. Large, symmetric ligands with arms designed 
to reach out to individual subunits have proven to be 
high-affi  nity ligands for homomeric CNG (  Kramer and 
Karpen, 1998  ) and Kv channels (  Gradl et al., 2003  ). 
A fascinating venture would be to break the symmetry of 
these lead molecules and attach subunit-specifi  c chemi-
cal moieties to enable selective targeting of hetero-
oligomeric proteins. Therein lies a real challenge with 
enormous potential impact! 
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